3E Bioventures Capital — Full Portfolio

Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets.

BiotechDeep TechHardwareHealthtechMedical DevicesBellevue, US

WJWenbin Jiang, Ph.D.(CEO and Chairman of the Board)Wenbin Jiang(Executive Officer, Director)inMYMing Yan, Ph.D.(Chief Technology Officer)Ming Yan(Executive Officer, Director)inJiecheng Zhang(Director)Allen Poirson(Director)

Co-investorsF-F-Prime CapitalNONorthern Light Venture CapitalRARA Capital

Profusa develops injectable hydrogel biosensors and AI-driven health platforms that enable real-time measurement of body chemistry from within tissue.

AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Francisco, US

Bill Fawcett(Co-founder)NWNatalie Wisniewski(Executive Officer, Director)inBHBen Healy(CEO)Ben Hwang(Executive Officer, Director)in

BoardQianye Karen Liu(Director)Thomas Gutshall(Director)

Co-investorsASAsset Management CompanyATAtinum Investment Co. Ltd.SASand Hill AngelsBIBioVentures

Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals.

BiotechDeep TechSemiconductorsSouth San Francisco, US

William Charles Banyai(Executive Officer, Director, Promoter)BJBill James Peck(Executive Officer, Promoter)ELEmily Leproust(Founder)inEMEmily M. Leproust(Chief Executive Officer and Chair of the Board)inPFPatrick Finn(President and Chief Operating Officer)inALAdam Laponis(Chief Financial Officer)in

Co-investors+N+ND CapitalARARCH Venture PartnersASAsset Management CompanyBABay City CapitalBLBlack Opal VenturesDEDentsu Ventures+8 more

Arnatar develops a next-generation RNA discovery platform called DARGER that combines gene silencing and gene upregulation technologies for oligonucleotide therapeutics.

AI & Machine LearningBiotechDeep Tech

DXDr. Xuehai Liang(Founder)DYDr. Yanfeng Wang(Founder & Chief Operating Officer)

Co-investorsF-F-Prime CapitalAPApricot CapitalEIEight Roads VenturesGAGaorong VenturesLELegend StarNENew Alliance Capital

Dermaliq Therapeutics is a specialty pharmaceutical company developing topical dermatology therapies and medical skin care products based on its proprietary hyliQ drug-delivery platform, with a lead pipeline focused on hair loss conditions such as androgenetic alopecia and alopecia areata.

BiotechHealthtechWilmington, US

Oliver Schlüter(CFO & Co-Founder)Betsy Hughes-Formella(CSO & Co-Founder / R&D Consultant)Christian Roesky(CEO & President)

ProNovo Therapeutics is a biotechnology company developing precision small-molecule therapeutics for neuropsychiatric disorders, including Major Depressive Disorder and Schizophrenia.

BiotechHealthtechMental Health

Guang Chen(Founder, Board Director & Chief Scientific Officer)inXiaohu Deng(Co-Founder & CEO)inScott Thompson(Co-Founder & Chair of Scientific Advisory Board)in

Co-investorsGAGaorong Ventures

An innovative biopharmaceutical company focused on developing therapies for chronic kidney disease across multiple clinical stages, with a pipeline of eight products covering conditions such as hyperphosphatemia, renal anemia, IgA nephropathy, and diabetic kidney disease.

BiotechDigital HealthHealthtechMedical DevicesShanghai, CN

Co-investorsLALAVLILilly Asia VenturesQUQuan Capital3H3H Health InvestmentSHSherpa Healthcare PartnersYUYuanBio Venture Capital

BiotechHouston, US

AGAmato Giaccia(Director)Rudy Howard(Chief Financial Officer)Robert B. Geller(Chief Medical Officer)inGail McIntyre(Chief Executive Officer)LSLeonard Scott Dove(Chief Operating Officer)Joshua Brumm(Executive Officer)

Co-investorsADAdvent Life SciencesESEshelman Ventures, LLC

Avirmax is a preclinical-stage biopharmaceutical company developing AAV-based genetic medicines to treat chronic and degenerative ocular diseases.

BiotechDeep TechMedical DevicesHayward, US

HCHaifeng Chen(Director and Treasurer of the Issuer)inShengjiang Liu(Executive Officer, Director)

BoardYu Fang(Director of the Issuer)Qianye Karen Liu(Director of the Issuer)Nancy Chang(Director of the Issuer)

Co-investorsBIBioVentures

Cognition Therapeutics is a clinical-stage biotechnology company developing zervimesine (CT1812), an investigational once-daily oral small-molecule therapy designed to protect brain synapses by blocking toxic protein oligomers.

BiotechHealthtechPittsburgh, US

SCSusan Catalano(Executive Officer, Director)inSusan Catalano, Ph.D.(Co-founder)LRLisa Ricciardi(Chief Executive Officer)inHarold Safferstein(Executive Officer, Director)

BoardNada Jain(Director)Franz Hefti(Director)

Co-investorsATAtlanta Technology AngelsHOHouston Angel NetworkINiNetworksDODolby Family VenturesGOGolden Seeds

Cullgen is a privately held biopharmaceutical company developing first-in-class drugs based on its uSMITE™ (small-molecule induced ubiquitin-dependent target elimination) targeted protein degradation platform, which uses the ubiquitin-proteasome system and E3 ubiquitin ligases to target disease-causing proteins that conventional small-molecule drugs cannot reach.

BiotechDeep TechHealthtechMedical Devices

Ying Luo(CEO)in

Dewpoint Innovations develops functional nanostructured polymeric surfaces for atmospheric water capture, technology originating from PhD research at the University of Sydney.

CleantechClimate TechDeep TechNew Materials

CNChiara Neto(Founder & Advisor (Chief Scientific Officer))inMing Chiu(Founder & CTO)in

Co-investorsPAPacific ChannelARARCH Venture PartnersECEcoR1 CapitalGEGeneral CatalystLELeaps by BayerMAMaverick Ventures+2 more

Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.

AI & Machine LearningBiotechDeep TechBoston, US

RYRichard Young, Ph.D.(Director)AHAnthony Hyman, Ph.D.(Director)THTony Hyman(Scientific Co-founder)Rick Young(Scientific Co-founder)Elisabeth Leiderman(Executive Officer)inANAmeet Nathwani, M.D.(Executive Officer, Director)in

Co-investorsARARCH Venture PartnersECEcoR1 CapitalSASamsara BioCapital6 6 Dimensions CapitalGEGeneral CatalystINInnovation Endeavors+5 more

Eaglenos develops smart healthcare technologies, focusing on precision testing and personalized health management.

Digital HealthHealthtechMedical DevicesNanjing, CN

Epimab Biotherapeutics is a clinical-stage biopharmaceutical company specializing in the development of bispecific antibodies using proprietary technology platforms including FIT-Ig® and MAT-Fab.

BiotechHealthtechMedical DevicesShanghai, CN

Wu Chenbing(Founder/Expert)

Co-investorsDEDecheng CapitalSHShangBay Capital LLCTCTCG LabsSHSherpa Healthcare Partners

FA International provides technology and business development advisory services for industrial and medical device companies, helping them evaluate pre- and post-investment opportunities and technology risks to optimize returns and develop growth strategies.

Advanced ManufacturingDeep TechEnterprise SoftwareHardwareMedical Devices

Galaxy Brain Scientific develops personalized brain mapping and neuromodulation technologies for research and clinical applications across neurological conditions.

AI & Machine LearningBiotechDeep TechMedical Devices

Genotix Bio develops the DaVinci, a compact nanoarray analyzer that detects proteins and nucleic acids at single-molecule resolution for research applications.

BiotechDeep TechDigital HealthHealthtechMedical DevicesSan Francisco, US

Dr. Yong Chen(Co-founder)GBGeorge Brittain(Co-founder)inPMPan MaoinPGPhilippe Goix(CEO and Board Member)in

Lipidio Pharma is a drug development company that acquires molecules with unrealized therapeutic potential and advances them through preclinical and clinical development toward approval or exit.

BiotechHealthtechSan Diego, US

James Mackay(Co-Founder)David Bullough(Director)Daniel Petree(Director)J. Gordon Foulkes(Executive Officer, Director)

LumiThera develops the Valeda Light Delivery System, an FDA-authorized photobiomodulation (PBM) device that applies multiple light wavelengths to treat early and intermediate dry age-related macular degeneration (AMD).

BiotechHealthtechMedical DevicesPoulsbo, US

TPTracy Puckett(Executive Officer)Clark Tedford(Executive Officer, Director)inSBScott Bradley(Executive Officer)inDMDuane Morrison(Executive Officer)inCCCindy Croissant(Executive Officer)RMRyan Montecucco(Executive Officer)

Co-investorsLILife Sciences Greenhouse InvestmentsIMImagine VenturesKEKeiretsu Capital

Mediaspace is a digital agency that designs and builds custom Squarespace websites and provides SEO, digital marketing strategy, and digital advertising services.

AdTechAdvanced ManufacturingAI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHardwareHealthtechMarketing TechMedical DevicesSemiconductorsAtlanta, US

John G. Edwards(Executive Officer, Director)JJJohn Jacobi(Executive Officer)SPSri Peruvemba(Executive Officer)Francois Jeanneau(Executive Officer, Director)Linda Ara(Executive Officer)Michael Vestel(Executive Officer)

Co-investorsKEKeiretsu ForumLILife Sciences Greenhouse InvestmentsTOToba CapitalVIVivo Capital

Myrobalan Therapeutics is a pre-clinical biotech company developing small molecule therapies targeting microglia and oligodendrocytes to address neurodegeneration and demyelinating disorders.

AI & Machine LearningBiotechDeep TechMedical DevicesBoston, US

Jing Wang, PhD(Co-Founder & CEO)GFGuoping Feng, PhD(Scientific Co-Founder)ZHZhigang He(Scientific Co-founder)GFGuoping Feng(Scientific Co-founder)

OncoC4 is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer patients, based on research by its immunologist founders.

BiotechHealthtechRockville, US

YLYang Liu(Co-founder)inPZPan Zheng(Co-founder)inMartin Devenport(Executive Officer)Michael Flaschen(Director)

Co-investorsHMHM Venture Partners

First-in-class biologic drug targeting the CD24-Siglec innate immunity signaling pathway.

BiotechRockville, US

Pan Zheng(Executive Officer)Yang Liu(Executive Officer, Director)Martin Devenport(Executive Officer)

BoardMiao Hong(Director)Karen Liu(Director)inKun-Liang Guan(Director)

Co-investorsHMHM Venture Partners

Quadriga BioSciences is an oncology startup developing targeted small molecule chemotherapeutics for cancer treatment, with a focus on central nervous system malignancies and immune-mediated disorders.

BiotechHealthtechMedical Devices

Gordon Ringold(CEO)Bernd Jandeleit(Co-Founder)Wolf-Nicolas Fischer(Co-Founder)Kerry J. Koller(Co-Founder)

Rapafusyn develops molecular glue therapeutics using its RapaGlue platform of non-degrading macrocyclic compounds designed to modulate hard-to-drug intracellular and transmembrane protein targets.

AI & Machine LearningBiotechDeep TechBaltimore, US

JOJun O. Liu(Founder)

Co-investorsBIBioTrack Capital

Shanton Pharma is a clinical-stage biotech company developing drugs for gout, hyperuricemia, and pruritus.

BiotechHealthtech

Smartlens develops wearable microfluidic devices and AI-powered platforms for remote monitoring and diagnosis of anterior segment eye diseases, particularly glaucoma.

AI & Machine LearningDigital HealthHealthtechMedical Devices

SKSavas Komban(Founder)in

Co-investorsAMAmbit Health VenturesSTStanford University

Subtle Computing (legally Skywalk, Inc.) makes wireless earbuds sold directly at subtle.co and through authorized resellers, along with a companion mobile app.

AI & Machine LearningConsumerDirect to ConsumerHardware

TCTyler Chen(Founder)in

Co-investorsABAbstract VenturesENEntrada VenturesINInception Studio CapitalSLSLVCBABaidu VenturesBEBessemer Venture Partners+10 more

Subtle Medical develops deep learning software for medical imaging that enables faster and safer image acquisition on existing scanners for healthcare providers and imaging centers.

AI & Machine LearningHealthtechMedical Devices

GZGreg Zaharchuk(Co-founder, MD, Ph.D., Neuroradiologist and Professor at Stanford)inEGEnhao Gong(Co-founder, Ph.D., Deep Learning Scientist)in

Co-investorsATAtinum Investment Co. Ltd.BEBessemer Venture PartnersBRBreyer CapitalDCDCVC (Data Collective)FOFoothill VenturesFUFusion+2 more